Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

INSYS Therapeutics Inc (NASDAQ:INSY)

10.61
Delayed Data
As of Mar 24
 +0.04 / +0.38%
Today’s Change
8.70
Today|||52-Week Range
19.96
+15.33%
Year-to-Date

Today’s Trading

Previous close10.57
Today’s open10.57
Day’s range10.31 - 10.92
Volume725,276
Average volume (3 months)1,005,856
Market cap$761.5M
Dividend yield--
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)+48.08%
Earnings growth (this year)-77.90%
Earnings growth (next 5 years)+65.00%
Revenue growth (last year)+48.92%
P/E ratio34.2
Price/Sales6.55
Price/Book3.01

Competitors

----
AKAOAchaogen Inc+0.58+2.86%
ZIOPZIOPHARM Oncology In...+0.01+0.17%
VSARVersartis Inc+0.60+2.93%
Data as of 3:59pm ET, 03/24/2017

Financials

Next reporting dateMarch 27, 2017
EPS forecast (this quarter)-$0.01
Annual revenue (last year)$330.8M
Annual profit (last year)$58.5M
Net profit margin17.68%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive &
Medical Officer
Santosh J. Vetticaden
Chief Financial &
Accounting Officer
Darryl S. Baker
Corporate headquarters
Chandler, Arizona

Forecasts


Search for Jobs